The market for veterinary regenerative medicine is growing at a remarkable pace, with projections showing a surge from USD 344.9 million in 2024 to over USD 1.1 billion by 2034. This boom is a direct result of the "pet humanization" trend, where owners want the same advanced treatments for their animal companions that they would seek for themselves. 

Stem cell injections and other clinical interventions are leading this charge, offering new hope for conditions like osteoarthritis and ligament injuries. But for many pet owners, this cutting-edge care is out of reach due to high costs, invasive procedures that require anesthesia, and long recovery times. 

This has created a clear need for solutions that are both effective and accessible, a need that pioneers in regenerative nutrition like PetREGEN are working to meet.